Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy — Stella

Home/High Risk Pregnancy/IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

View on ClinicalTrials.gov

Recruiting

Back to High Risk Pregnancy trials

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Hospital for Special Surgery, New York, New York

University of Utah, Salt Lake City, Utah

Canada

TRIO Advancing Reproductive Care, Toronto, Ontario

Key details

Phase

Safety & dosing

Sponsor

David Ware Branch

Collaborators

Hospital for Special Surgery, New York, University of Toronto

Enrollment target

~55 participants

Started

May 2017

Primary completion

December 2027

Age range

18 Years – 40 Years

Sex

Female only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.